Chrono Therapeutics

At Chrono Therapeutics, we believe effective care of the most hard-to-treat conditions requires approaches beyond simply taking medicine. We are transforming how medicine is delivered and how people achieve their health goals through the convergence of optimized drug delivery, embedded sensor technology to monitor compliance, and connected and personalized behavioral support. Our First Product. Smoking is highly addictive and remains one of the world’s great killers. The World Health Organization estimates that the global death toll is 5 million per year and this is expected to rise to 7 million by 2020. Chrono's first application is in smoking cessation, enabling smokers to overcome the world's deadliest addiction.
Waltham, US
42 (est)-2%

Key People at Chrono Therapeutics

Guy DiPierro

Guy DiPierro

President & COO

Chrono Therapeutics Locations

Waltham, US

Chrono Therapeutics Metrics

Chrono Therapeutics Summary

Founding Date


Total Funding

$82.4 M

Latest funding size

$47.6 M

Time since last funding

about 1 month


Canaan Partners, GE Ventures, Mayo Clinic Rochester, 5AM Ventures, Fountain Healthcare Partners, National Cancer Institute (NCI)

Chrono Therapeutics News

Chrono Therapeutics Company Life